<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://practicalneurology.com/news/survaxm-vaccine-evaluated-in-phase-2b-trial-for-those-with-newly-diagnosed-glioblastoma/2488651/</loc><lastmod>2026-10-08T21:35:37+00:00</lastmod><news:news><news:publication><news:name>Practical Neurology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-08T21:27:00+00:00</news:publication_date><news:title>SurVaxM Vaccine Evaluated in Phase 2b Trial for Those With Newly Diagnosed Glioblastoma</news:title></news:news></url><url><loc>https://practicalneurology.com/news/zorevunersen-phase-3-study-for-dravet-syndrome-to-focus-on-seizure-control-and-adaptive-function/2488647/</loc><lastmod>2026-10-08T13:34:33+00:00</lastmod><news:news><news:publication><news:name>Practical Neurology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-07T22:23:00+00:00</news:publication_date><news:title>Zorevunersen Phase 3 Study for Dravet Syndrome to Focus on Seizure Control and Adaptive Function</news:title></news:news></url>
</urlset>
